I'm in my first year at university <a href=" http://www.aptech.com/buy-methocarbamol.pdf ">buy robaxin uk</a> The shares are up more than 60pc this year, yet the rating doesn&rsquo;t look that stretched despite the gains. We&rsquo;ve already had eight months&rsquo; trading in the current year and brokers have maintained forecasts for full-year revenue of £2.34bn, giving pre-tax profits of £540m, and earnings per share of 10.42p. That leaves shares trading on 17.4 times 2013 forecast earnings, falling to 15.8 times next year. With only four months of the year left it is really next year&rsquo;s rating that matters and that looks conservative if all this good news in the UK economy is to be believed, buy.